The proof is in the pudding: patient engagement in studying cannabidiol in mild cognitive impairment

The proof is in the pudding: patient engagement in studying cannabidiol in mild cognitive impairment

Abstract Background Patient engagement (PE) in clinical trials has gained importance yet remains uncommon, particularly in patients with mild cognitive impairment (MCI), a critical precursor to Alzheimer’s disease (AD). Cannabidiol (CBD) shows potential in slowing MCI progression due to its neuropro...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Antonia Keck, Julia-Sophia Scheuermann, Petra Scheerbaum, Elmar Graessel, Kirsten R. Müller-Vahl
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: BMC 2025-01-01
Seri Bilgileri:BMC Complementary Medicine and Therapies
Konular:
Mild cognitive impairment
Alzheimer’s disease
Cannabidiol
Cannabis-based medicine
Patient engagement
Patient and public involvement
Online Erişim:https://doi.org/10.1186/s12906-025-04753-w

Internet

https://doi.org/10.1186/s12906-025-04753-w

Benzer Materyaller